ALLMedicine™ Brachytherapy Center

May 3rd, 2022 - We aim to compare health-related quality of life (HRQoL) deterioration at 12 months in low-and intermediate-risk prostate cancer (PCa) patients treated with stereotactic ablative radiotherapy (SABR), high dose-rate brachytherapy (HDR) monotherapy ...

Apr 27th, 2022 - To evaluate whether the addition of radiation to adjuvant chemotherapy is associated with improved survival in women with stage IV endometrial cancer following surgery. The National Cancer Database (NCDB) and Surveillance, Epidemiology, and End Re...

Apr 27th, 2022 - The bi-centric XXX phase II trial investigates the implementation of molecular imaging with positron-emission tomography targeting prostate-specific-membrane-antigen (PSMA-PET) into modern focal dose-escalation radiotherapy (RT) concepts in 2 non-...

Apr 14th, 2022 - Continuing therapy for aggressive non-small-cell lung cancer (NSCLC) after first-line treatment (FLT) is challenging. The clinical efficacy of second-line chemotherapy (SLCT) for progressive NSCLC is limited. In this meta-analysis, we aim to evalu...

Apr 13th, 2022 - We compared the oncological outcomes of patients who received seed brachytherapy (SEED-BT) with those who received radical prostatectomy (RP) for intermediate-risk prostate cancer. Candidates were patients treated with either SEED-BT (n = 933) or ...

Oct 8th, 2020 - NEW YORK (Reuters Health) - Long-term survival among men with intermediate-risk prostate cancer did not differ regardless of whether they received stereotactic body radiation therapy (SBRT), dose-escalated external beam radiation (DE-EBRT) or brac...

Oct 8th, 2020 - NEW YORK (Reuters Health) - Long-term survival among men with intermediate-risk prostate cancer did not differ regardless of whether they received stereotactic body radiation therapy (SBRT), dose-escalated external beam radiation (DE-EBRT) or brac...

Oct 2nd, 2017 - SAN DIEGO — In women with early-stage, high-risk endometrial cancer, adding chemotherapy to radiation therapy was not superior to the standard treatment of radiation alone, according to new findings. In a head-to-head trial of two adjuvant strateg...

Oct 2nd, 2017 - SAN DIEGO — In women with early-stage, high-risk endometrial cancer, adding chemotherapy to radiation therapy was not superior to the standard treatment of radiation alone, according to new findings. In a head-to-head trial of two adjuvant strateg...

Oct 16th, 2015 - Hello. I am Dr Gerald Chodak for Medscape. Today, I want to talk about high-dose-rate temporary brachytherapy (HDRTB) for men with high-risk prostate cancer. I came across an article on Prostate Cancer Infolink that cited three randomized trials r...